Monashee Investment Management’s Avalo Therapeutics AVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-250	Closed	-$105K	–	72
2023 Q1	$105K	Buy	+250	New	+$105K	0.03%	54
2021 Q4	–	Sell	-94	Closed	-$589K	–	56
2021 Q3	$589K	Buy	+94	New	+$589K	0.11%	127